UK markets close in 4 hours 17 minutes

Autolus Therapeutics plc (AUTL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.8000-0.2000 (-5.00%)
At close: 04:00PM EDT
3.8800 +0.08 (+2.11%)
After hours: 06:18PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,698
1,698
6,194
1,507
242
Operating expenses
Research development
130,481
130,481
117,354
110,839
134,888
Selling general and administrative
46,745
46,745
31,899
31,865
34,972
Total operating expenses
177,226
177,226
149,087
141,881
168,387
Operating income or loss
-175,528
-175,528
-142,893
-140,374
-168,145
Interest expense
45,067
45,067
8,905
1,105
0
Total other income/expenses net
-1,312
-1,312
1,523
-821
1,352
Income before tax
-208,402
-208,402
-148,567
-142,038
-166,257
Income tax expense
-19
-19
272
58
-24,163
Income from continuing operations
-208,383
-208,383
-148,839
-142,096
-142,094
Net income
-208,383
-208,383
-148,839
-142,096
-142,094
Net income available to common shareholders
-208,383
-208,383
-148,839
-142,096
-142,094
Basic EPS
-0.98
-1.20
-1.57
-1.97
-2.76
Diluted EPS
-0.98
-1.20
-1.57
-1.97
-2.76
Basic average shares
157,140
173,942
94,993
72,084
51,558
Diluted average shares
157,140
173,942
94,993
72,084
51,558